Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-465604

Director sold 10,000 shares at an average $72.67 ($726,678)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WILSON JAMES N · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Sale : show line 1 in the form 10b5-1 −2,191 $71.80 $157,316 1,052,352 I
2026-11-13 Sale : show line 2 in the form 10b5-1 −7,221 $72.87 $526,170 1,045,131 I
2026-11-13 Sale : show line 3 in the form 10b5-1 −563 $73.42 $41,335 1,044,568 I
2026-11-13 Sale : show line 4 in the form 10b5-1 −25 $74.28 $1,857 1,044,543 I
Open-market sales · 10,000 sh · avg $72.67 · $726,678
Loading xslF345X06/ownership.xml…